NCT05716607View on ClinicalTrials.gov

Treatment Study in Patients Treated With Both Insulin & Hydrocortisone

NANot yet recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Diabetes MellitusAdrenal InsufficiencyPolyglandular Autoimmune Syndrome
Interventions
DRUG

OD dual-release Hydrocortisone

Treatment with once-daily dual-release hydrocortisone

DRUG

TID Hydrocortisone

Treatment with thrice-daily conventional immediate-release hydrocortisone

Trial Locations (1)

Unknown

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

The Swedish Society of Medicine

OTHER

collaborator

Åke Wibergs Stiftelse

UNKNOWN

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Pilloxa

INDUSTRY

lead

Vastra Gotaland Region

OTHER_GOV

NCT05716607 - Treatment Study in Patients Treated With Both Insulin & Hydrocortisone | Biotech Hunter | Biotech Hunter